Abstract
This article briefly reviews the epidemiology, diagnosis, and treatment of the common gynecologic malignancies, with an emphasis on the shortcomings of current clinical practice. The persistent need to achieve early diagnosis, adjust proper treatment, enhance surveillance, and improve the outcome of these patients has led to the development of new diagnostic modalities. Novel tools such as 18F-fluorodeoxyglucose PET/CT should aim at enhancing the clinician's ability to make critical decisions in treating difficult scenarios.
| Original language | English |
|---|---|
| Pages (from-to) | 391-405 |
| Number of pages | 15 |
| Journal | PET Clinics |
| Volume | 5 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 2010 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Best practice
- Cross-sectional imaging
- F-Fluorodeoxyglucose PET
- Gynecologic cancer
Fingerprint
Dive into the research topics of 'PET/CT in gynecologic cancer: Present applications and future prospects - A clinician's perspective'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver